SPOCD1 and ovarian cancer: Thus, our findings suggest that SPOCD1-AS from ovarian cancer-secreted EVs remodels recipient mesothelial cells in a MMT way, making mesothelial cells in a status conductive to peritoneal implantation of cancer cells.